Latest News about Jazz
Recent news which mentions Jazz
3 Healthcare Stocks That Could Make You Richer
October 05, 2022
From Motley Fool
Got $2,000? Buy These 2 Bear Market-Beating Growth Stocks
October 02, 2022
From Motley Fool
Japan Is Inching Toward Cannabis Legalization, Companies Like This One Could Benefit
September 29, 2022
Tickers
JAZZ
From Benzinga
UBS Slashes PT On This Stock By Over 89%? Plus Evercore ISI Group Predicts $150 For First Solar
September 29, 2022
From Benzinga
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
September 23, 2022
From Motley Fool
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
September 22, 2022
From Motley Fool
5 Analysts Have This to Say About Jazz Pharmaceuticals
September 21, 2022
Tickers
JAZZ
From Benzinga
Is It Too Late to Buy Axsome Therapeutics Stock?
September 17, 2022
From Motley Fool
7 Top-Rated Biotech Stocks to Buy for Q4
September 15, 2022
From InvestorPlace
3 Top Pot Stocks to Watch in September
September 15, 2022
From Motley Fool
Is Axsome Therapeutics a Buy?
September 09, 2022
From Motley Fool
New Music Alert! Award-Winning Artist & Music Producer, Sonix releases, 'Love Crusade,' full-length LP, & 'No Ordinary Love The Maxi Single' 9.9.2022
September 08, 2022
Tickers
JAZZ
From PRLog
2 Growth Stocks That Are Beating Amazon Without Breaking a Sweat
September 03, 2022
From Motley Fool
2 Top Healthcare Stocks Defying the Bear Market
August 22, 2022
From Motley Fool
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
From Benzinga
Jazz' Epidiolex, The Only FDA-Approved CBD Drug, Enters Phase 3 Trial Evaluating Its Effects In Patients With Myoclonic-Atonic Seizures
August 18, 2022
Tickers
JAZZ
From Benzinga
Why Axsome Therapeutics Topped the Market Today
August 09, 2022
From Motley Fool
Jazz Pharmaceuticals' Return On Capital Employed Insights
August 08, 2022
Tickers
JAZZ
From Benzinga
From Benzinga
From Motley Fool
7 Biotech Stocks to Buy for Q3
July 18, 2022
From InvestorPlace
From Benzinga
Why BioXcel Therapeutics Was a Winner This Week
July 08, 2022
From Motley Fool
From Motley Fool
Brazilian Fund Invests $19M In US Cannabis Stocks
July 05, 2022
From Benzinga
What Bear Market? These 2 Stocks Are Killing It.
July 01, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.